RESUMEN
Objective:By retrieving published patents on novel coronavirus related technologies, we analyzed the differences in patent applicants, target areas, patent quality, etc. in different countries and regions, and learned from the patent layout of relevant key innovation entities in countries and regions with relatively mature patent systems, such as Europe and the United States, to provide a reference for the subsequent writing and layout of related Chinese patents.Methods:" Novel coronavirus pneumonia, nCov pneumonia, novel coronavirus, nCov, COVID-19, 2019-nCoV, SARS-CoV-2" were searched as key words in the PatSnap Patent Database, with a limitation of public date before September 30, 2020. Based on the bibliometric method, this study analyzed applicants, regional distribution, patent quality, patent subject, etc.Results:4 541 patents on novel coronavirus related technology were obtained through search and filtering, whose applicants are mainly from China, which is also the major, region of applications. However, in an analysis of patent quality regarding novel coronavirus related technologies, the number of claims of US patent applications reached 44.48, and the number of patents in the same family reached 5.21, while in China, the numbers were just 9.27 (claims) and 1.45 (patents of the same family).Conclusions:China outperformed other countries in terms of the number of patent applications for novel coronavirus related technologies, but fell rather far behind the US in terms of patent quality and layout. Therefore, it is necessary to introduce and train professional patent management talents, improve the patent management system, raise awareness of patent legal protection, write high-quality legal documents, attach importance to the global market of patent technology, and strengthen the internationalization of patent layout, further promote industry-university-research cooperation, strengthen exchanges and cooperation among research institutions, pharmaceutical enterprises, hospitals and other institutions, pay attention to the combination of scientific research and clinical, prevention and control practices, and promote the healthy development of coronavirus research.
RESUMEN
OBJECTIVE：To provide reference for optimizing resource allocation and precise investment of China ’s pharma- ceutical industry. METHODS ：The number of invention patent applications in China ’s pharmaceutical industry was searched from China Intellectual Property Netwerk ，and the status quo and structure of patent applications in China ’s pharmaceutical industry were analyzed. SPSS 23.0 software was used to analyze the input-output correlation of the number of invention patent applications with R&D investment and main business income of pharmaceutical enterprises in China. RESULTS ：The number of invention patent applications in China ’s pharmaceutical industry increased year by year. From 2000 to 2015，225 861 invention patents had been applied by domestic applicants and 43 149 invention patents had been applied by foreign applicants in China ；only 49.94％ domestic applicants applied for professional invention ，while 96.79％ of foreign applicants applied for professional invention. There was a positive correlation between the R&D expenditure of pharmaceutical enterprises and the number of invention patent applications，which indicated that the R&D investment of pharmaceutical industry in China was beneficial to the invention patent applications. The number of invention patent applications of pharmaceutical enterprises was also positively correlated with the main business income ，indicating that the increase of invention patent applications of pharmaceutical enterprises also effectively expanded the economic scale of pharmaceutical industry. CONCLUSIONS ：Compared with foreign countries ，the structure of patent applicants in domestic pharmaceutical industry needs to be adjusted urgently. Pharmaceutical enterprises have not yet become the main applicants. The continuous R&D investment of pharmaceutical enterprises effectively promotes the application of invention patent，expanded the economic scale of the pharmaceutical industry.
RESUMEN
The research literature of Laportea bulbifera was summarized and analyzed, and its distribution of literature, chemical composition, pharmacological activity, quality control, clinical application and patent approval were summarized, this study can provide reference for the follow-up clinical application and development and utilization of the herb. Taking CNKI and PubMed database as the retrieval platform, keywords and full text as the search items, the Honghema, Honghuoma, Zhuya Aima, Laportea bulbifera (Siebold & Zuccarini) Weddell. and Laportea bulbifera as the search terms, the domestic and foreign paper reports and patent approvals of L. bulbifera from 1989 to 2018 were retrieved. A total of 41 papers and 63 patents were reviewed, the contents of these papers were pharmacological activity, chemical composition and quality control research, the majority of patents were compound. At present, 73 chemical constituents have been isolated and identified from L. bulbifera, and most of them were flavonoids. Flavonoids, catechins and coumarins were selected as the quality control indexes, and most of the pharmacological activities were anti-inflammatory, analgesic and anti-rheumatism. L. bulbifera is highly competitive in the market because of its remarkable pharmacological activities, however, its quality control level in local standard is low and testing items are incomplete. The determination reported in the literature lacks specific indexes to evaluate the quality of L. bulbifera, at the same time, it is necessary to further study its anti-inflammatory mechanism, explore its quality markers and establish the spectrum-effect relationship, so as to effectively control the quality of L. bulbifera and provide documentation for its comprehensive utilization and resource development.
RESUMEN
Objective To share the experience of the patent application,authorization,and transfer in a hospital in last five years,this study aims to improve the patent application and authorization in hospitals.Methods Using data from China Patent Infonet and State Intellectual Property Office of People's Republic of China,we searched the patent application and authorization during Jan.2012 to Dec.2016,and included those that patentee was our hospital or the employee of our hospital.Results The number of patent applications was 215,including 151 service intention-creation applications,and 64 non-service intention-creation applications.Patent application and authorization in our hospital have been increasing year by year,covering internal medicine,surgery,obstetrics and gynecology,pediatrics and so forth.Conclusions We accumulated some experience in patent application,authorization and transfer which provide reference for further,more comprehensive and integrated,patent management system.
RESUMEN
Artemisiae Annuae Herba is dry aboveground part of Artemisia annua, which has a long history of application in China. Modern research achievements make it shiny all over the world. The breakthrough in modern research also attracts a lot of attention and related research, and now a lot of achievements have been made. In order to perform further research purposefully, systematic review of existing achievements was made to understand industry pattern and development prospect. And the patent document is one of the important science and technology literature source. The patent information was collected from several special patent database, and the patent and industrial structure in the field comprehensively was analyzed with the aid of computer science, including life cycle, geographical distribution, international exchange, efficacy preferences, compatibility strategy, excellent application institutions, and high value patents. The result shows that the field has sizable development space, which should make use of the analysis result of the paper to formulate development strategies in line with our own.
RESUMEN
Traditional Chinese medicine (TCM) is a treasure of five-thousand-year civilization of China, with systemic theory and reliable clinical efficacy. As the origin of TCM, China should have a large number of independent intellectual property rights of TCM beyond any doubt. However, the quality of TCM patent application as a whole is far from optimistic currently. Targeting the differences in number and quality of TCM patent application in China, this article analyzed current situation of TCM patent application, discussed the reasons and offered countermeasures, and proposed that the work focus of intellectual property in China should shift from quantity to quality. It also argued that targeted countermeasures should be chosen according to the causing reasons, and overall promotion of the TCM intellectual property competiveness should be achieved through multi-aspect and multi-department cooperation.
RESUMEN
Composition of invention patent application is important for obtaining patent right and maintaining the right stability. According to the features of TCM invention patent application and common problems in examination, this article summarized several key points for effective application composition, including composing background technology objectively, highlighting technical problems, reasonable layout of technical pian, working in contact with technical effects, and clarifying technical terms. It expounded each point with relevant typical cases, with a purpose to provide references for applicants and agents of TCM invention patent application.
RESUMEN
In order to show the development situation and trend in plaque research, Thomson Innovation Platform-covered application of patents associated with plaque researches was quantitatively analyzed using the Thomson Data Analyzer and Thomson Innovation or other tools, which revealed the overall development situation, the main accepted countries, the main application institutions and the technological direction layout of patents associated with plaque researches.
RESUMEN
OBJECTIVE:To compare the economic value between patent application and know-how,the two measures for intellectual property rights protection of traditional Chinese medicine.METHOD:The legal features of intellectual property rights protection for Chinese traditional medicine were analyzed and its economic value was evaluated with economic model.RESULTS&CONCLUSION:The know-how has a greater economic value to enterprises under the current intellectual property rights protection system.